Skip to main content

Advertisement

Log in

Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

PALB2 is a breast and pancreas cancer susceptibility gene whose protein is closely associated with BRCA2 and is essential for BRCA2 anchorage to nuclear structures. This functional relationship made PALB2 a candidate gene for susceptibility to BRCA2-related cancers such as melanoma. The purpose of this study was to screen for the presence of germline mutations in PALB2 in familial melanoma cases. We sequenced the exons and intron–exon boundaries of PALB2 in probands from 53 families with familial melanoma where CDKN2A mutations were absent. A number of previously reported coding and non-coding variants were observed. However, no truncating mutations were identified. These results indicate that deleterious PALB2 mutations are unlikely to play a significant role in familial melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Meyle KD, Guldberg P (2009) Genetic risk factors for melanoma. Hum Genet 126(4):499–510

    Article  PubMed  CAS  Google Scholar 

  2. Hussussian CJ, Struewing JP, Goldstein AM et al (1994) Germline p16 mutations in familial melanoma. Nat Genet 8(1):15–21

    Article  PubMed  CAS  Google Scholar 

  3. Goldstein AM, Chan M, Harland M et al (2006) High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across Genomel. Cancer Res 66(20):9818–9828

    Article  PubMed  CAS  Google Scholar 

  4. Consortium BreastCancerLinkage (1999) Cancer risks in BRCA2 mutation carriers.The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91(15):1310–1316

    Article  Google Scholar 

  5. Ginsburg O, Kim-Sing C, Foulkes W et al. (2010) BRCA1 and BRCA2 families and the risk of skin cancer. Fam Cancer 1–5. doi: 10.1007/s10689-010-9377-y

  6. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665–676

    Article  PubMed  CAS  Google Scholar 

  7. Xia B, Sheng Q, Nakanishi K et al (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22(6):719–729

    Article  PubMed  CAS  Google Scholar 

  8. Tischkowitz M, Xia B (2010) PALB2/FANCN: recombining cancer and Fanconi anemia. Cancer Res 70(19):7353–7359

    Article  PubMed  CAS  Google Scholar 

  9. Tischkowitz M, Xia B, Sabbaghian N et al (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104(16):6788–6793

    Article  PubMed  CAS  Google Scholar 

  10. Rahman N, Seal S, Thompson D et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Susan G. Komen Foundation for the Cure and the Jewish General Hospital Weekend to End Breast Cancer. MT holds a Fonds de la Recherche en Santé du Québec (FRSQ) clinician-scientist award.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Tischkowitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabbaghian, N., Kyle, R., Hao, A. et al. Mutation analysis of the PALB2 cancer predisposition gene in familial melanoma. Familial Cancer 10, 315–317 (2011). https://doi.org/10.1007/s10689-010-9405-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-010-9405-y

Keywords

Navigation